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Abstract.  Novel proteins unique to either transverse 
tubules (TS28) or the sarcolemma (SL50) have been 
identified and characterized,  and their in situ distribu- 
tion in rabbit skeletal muscle has been determined 
using monoclonal antibodies. 
TS28, defined by mAb IXEll2,  was shown to have 
an apparent relative molecular mass of 28,000 D. Bio- 
chemical studies showed that TS28 is a minor mem- 
brane protein in isolated transverse tubular vesicles. 
Immunofluorescence and immunoelectron microscopi- 
cal studies showed that TS28 is localized to the trans- 
verse tubules and in some subsareolemmal vesicles 
possibly corresponding to the subgroup of caveolae 
connecting the transverse tubules with the sar- 
colemma.  In contrast,  TS28 is absent from the lateral 
portion of the sarcolemma.  Immunofluorescence 
studies also showed that TS28 is more densely dis- 
tributed in type II (fast) than in type I (slow) 
myofibers. Although TS28 and the  1,4-dihydropyridine 
receptor are both localized to transverse tubules and 
subsarcolemmal vesicles, TS28 is not a  wheat germ 
agglutinin  (WGA)-binding glycoprotein and does not 
appear to copurify with the 1,4-dihydropyridine recep- 
tor after detergent solubilization of transverse tubular 
membranes. 
SL50, defined by mAb IVD31, was shown to have an 
apparent relative molecular mass of 50,000 D.  Bio- 
chemical studies showed that SL50 is not related to 
the 52,000-D (B subunit) of the dihydropyridine recep- 
tor but does bind to WGA-Sepharose. Immunofluores- 
cence labeling imaged by standard and confocal mi- 
croscopy showed that SL50 is associated with the 
sarcolemma but apparently absent from the transverse 
tubules. Immunofluorescence labeling also showed that 
the density of SL50 in type II (fast) myofibers is indis- 
tinguishable from that of type I (slow) myofibers. 
The functions of TS28 and SL50 are presently un- 
known.  However, the distinct distribution of TS28 to 
the transverse tubules and subsarcolemmal vesicles as 
determined by immunocytochemical labeling suggests 
that TS28 may be directly involved in excitation- 
contraction coupling.  Our results demonstrate that,  al- 
though transverse tubules are continuous with the sar- 
colemma,  each of these membranes contain one or 
more unique proteins,  thus supporting the idea that 
they each have a distinct protein composition. 
XCITATION-CONTRACTION coupling in skeletal mus- 
cle requires a message elicited during depolarization 
of the sarcolemma to cross the gap between the trans- 
verse tubules and the terminal  cisternae of the sarcoplasmic 
reticulum.  This message induces a release of Ca  2÷ from the 
sarcoplasmic reticulum,  thus resulting in contraction.  To un- 
derstand the specific function of transverse tubules in excita- 
tion-contraction  coupling,  it is  important  to  identify and 
characterize  the structure  and function of transverse tubular 
membrane proteins. 
Presently, two distinct approaches are used to purify trans- 
verse tubules.  According to one procedure, transverse tubu- 
lar membrane vesicles are obtained by French press dissoci- 
ation  of isolated  triads  (6,  28).  Alternatively,  transverse 
tubules  are purified  from calcium phosphate-loaded  sar- 
coplasmic reticulum by sucrose density centrifugation  (40). 
Both transverse tubular membrane preparations  are charac- 
terized by a high density of high affinity 1,4-dihydropyridine 
receptors.  However, they differ considerably with respect to 
their content of enzyme activities  (e.g.,  [Na+,K÷]-ATPase 
and Mg2÷-ATPase), considered to be markers of the plasma 
membrane.  To date, the reason for these differences has not 
been elucidated. 
The  finding  that  the  high  affinity  1,4-dihydropyridine 
receptor is  30-fold  more densely distributed  in transverse 
tubular membrane vesicles than in sarcolemmal  membrane 
vesicles from skeletal muscle suggested that this protein is 
confined to transverse tubular membrane (13). Recent elec- 
trophysiological  evidence supports the view that  the  1,4- 
dihydropyridine  receptor acts as a voltage sensor essential 
for excitation-contraction  coupling  (38, 44). Determination 
of the  subcellular  distribution  of the  1,4-dihydropyridine 
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munocolloidal gold labeling confirmed that the o~, subunit 
of the  1,4-dihydropyridine receptor is indeed densely dis- 
tributed in the transverse tubules and apparently absent from 
the lateral portion of the sarcolemma. Unexpectedly, the ix, 
subunit of the 1,4-dihydropyridine receptor was also found 
to localize over some subsarcolemmal vesicles, possibly cor- 
responding to a subpopulation of sarcolemmal invaginations 
called  caveolae (25).  Thus,  it appears  that  immunocyto- 
chemical labeling in situ provides an alternative and power- 
ful  approach  to  determining  whether  proteins  present  in 
purified transverse tubules are indeed localized to transverse 
tubules in situ and if so whether they are unique to transverse 
tubules or also present in other skeletal muscle membranes 
(i.e., caveolae). To identify and characterize the structure, 
function, and subcellular distribution of other proteins pres- 
ent in isolated transverse tubular membranes, we have begun 
to prepare monoclonal antibodies to isolated transverse tubu- 
lar membrane vesicles. 
In this paper, we report on the identification, characteriza- 
tion, and subcellular localization of two novel rabbit skeletal 
muscle proteins each defined by a monoclonal antibody pre- 
pared against isolated transverse tubular membrane vesicles 
by hybridoma technology. Immunochemical studies showed 
that mAb IXEll2 defines a  novel skeletal muscle protein 
with an apparent relative molecular mass of  28,000 D. Immu- 
nocytochemical studies showed that this protein localizes to 
the transverse tubules but is apparently absent from the sar- 
colemmal membranes of the skeletal muscle. It is also pres- 
ent in some subsarcolemmal vesicles, possibly representing 
a  subgroup of caveolae connecting the transverse tubules 
with  the  sarcolemma.  The  mAb  IVD3t  defines  another 
novel rabbit skeletal muscle protein with an apparent relative 
molecular mass of 50,000 D. Immunocytochemical studies 
showed that this protein is associated with the sarcolemma 
but apparently absent from transverse tubules of adult rabbit 
skeletal muscle. 
Materials and Methods 
Preparation of  Skeletal Muscle Extract, Triads, 
Transverse Tubular Membranes, and the 
1,4-Dihydropyridine Receptor 
Skeletal  muscle extracts represent the postnuclear supernatant obtained 
from tissue homogenates during the preparation of light sarcoplasmic retic- 
ulum (3). Triads were prepared as described by Mitchell et al. (34) with 
slight modification (42). Transverse tubular membranes were prepared by 
the method of Rosemblatt et al. (40). Light sarcoplasmic reticulum was pre- 
pared as previously described (3). The  1,4-dihydropyridine receptor was 
purified as described by Campbell and Kahl (2).  Protein concentrations 
were determined by the method of Lowry et al. (31) as modified by Peterson 
(35)  using BSA as a standard. 
Preparation of  Monoclonal Antibodies 
Monoclonal antibodies were prepared by hybridoma technology as previ- 
ously described (29)  using spleens from mice immunized with isolated 
transverse tubular membranes. Hybridoma supernatants were screened by 
an immunodot assay (4) against the following membrane and protein frac- 
tions purified from rabbit skeletal muscle:  light sarcoplasmic reticulum, 
triads, transverse tubules, and  1,4-dihydropyridine receptor. Supernatants 
positive for transverse tubules and triads but negative for light sareoplasmic 
reticulum and 1,4-dihydropyridine receptor were further screened by immu- 
noblotting and immunofluorescence labeling, mAb VD2b to the/~ subunit 
of the 1,4-dihydropyridine receptor, was prepared as previously described 
(30). 
lmmunoblotting 
SDS-PAGE was performed by the method of Laemmli (27) in either 3-12 % 
or in 7.5-12% acrylamide gels. Transblotting of proteins from SDS-PAGE 
gels and immunoblotting was performed according to the methods of TOW- 
bin et al.  (45)  with minor modifications as outlined in immunoblotting 
procedures A and B (see below). 
Procedure  A.  Nitrocellulose blots were blocked in 5% nonfat dry milk 
in TBS (20 mM Tris, 500 mM NaCI [pH 7.4]) (19). The antibody incubation 
medium included 2.5% nonfat dry milk in TBS.  An affinity-purlfied goat 
anti-mouse IgG-alkaline phosphatase conjugate (1:3,000; Bio-Rad Labora- 
tories Ltd., Mississauga, Ontario, Canada) was used as secondary antibody 
for immunoblotting with mAb 1XE112 according to the procedure of Blake 
et al.  (1). Immunoblotting with mAb IVD31  to SL50 was carded out as 
referenced above except that a triple layered procedure was used. Thus, the 
incubation with mAb IVD31 (l:l,O00)  was followed first by afffinity-purified 
F(ab')2 fragments of goat anti-mouse IgG (Fc specific) conjugated to biotin 
(1:3,000 dilution; Jackson Immunoresearch Laboratories Inc., West Grove, 
PA) and then by avidin-conjugated alkaline phosphatase (1:1,000; Bio-Rad 
Laboratories Ltd.). 
Procedure R  Nitrocellulose blots were blocked for 1 h in biotto (50 mM 
sodium phosphate, pH 7.4 150 mM sodium chloride, 5% nonfat dry milk). 
The blots were incubated for 1 h with mAb IXEII2 or overnight with mAb 
IVD31 in blotto at a dilution of I:1,000.  Nitrocellulose blots were washed 
three times and then incubated with peroxidase-conjugated  goat anti-mouse 
IgG (Sigma Chemical Co., St. Louis, MO) at a dilution of 1:1,000. They 
were then washed three times with blotto and developed using 4-chloro-l- 
naphthol as a substrate. 
Preparation of  Cross-linked Monoclonal 
Antibody Beads 
Protein A-Sepharose beads (Sigma Chemical Co.) were hydrated overnight 
in TBS (150 mM NaCI, 50 mM "Iris [pH 7.4]).  2 ml of beads were then 
incubated with 10 ml of hybridoma supernatant from the cell line IXEII2 
for 24 h with three changes of media. The antibody was then covalently 
linked to the protein A beads by the method of Harlow and Lane (17) using 
dimethyl suberimidate (14) as a cross-linking agent. 
Affinity Chromatography on Protein  A-Sepharose: 
mAb IXEll  2  Beads 
1 mg of isolated transverse tubular membrane vesicles was solubilized in 
2 ml of 1% digitonin, 0.5 M sucrose, 0.5 M NaCI, 50 mM Tris (pH 7.4), 
0.83 mM benzamidine. The supernatant (750/~1) was then incubated with 
1 ml of protein A-IXEI12 cross-linked beads as prepared above or with 
1 ml  of wheat germ agglutinin  (WGA)l-Sepharose beads.  The  affinity 
column void or the WGA-Sepharose void were then run on SDS-PAGE and 
either stained with Coomassie brilliant blue or transferred and immunoblot- 
ted with IXEll2 using procedure B as described above. 
Dissection, Fixation, and Sectioning of 
Adult Skeletal Muscle 
Fixed and unfixed bundles of skeletal muscle fibers from rabbit gracilis, di- 
aphragm and psoas muscle were prepared as previously described (22). 
Briefly,  bundles of myofibers were dissected and quickly frozen in liquid 
nitrogen-cooled isopentane. Bundles of myofibers to be fixed were dis- 
sected and immediately tied to applicator sticks (for chemical fixation) or 
stainless steel loops (for cryofixation) at 100-120% of their rest length and 
allowed to recover for 30 min in a modified Krebs-Henseleit  buffer (145 mM 
NaC1, 2.6 mM KCI, 5.9 mM CaCI2,  1.2 mM MgSO4,  25 mM NaHCO3, 
and  10 mM glucose saturated with a  mixture of 95%  02 and 5% CO2). 
The bundles of myofibers to be used for immunofluorescence studies were 
fixed for 3 h in ice-cold 2% paraformaldehyde in 0.1 M sodium cacodylate 
(pH 7.4). Sucrose infusion, storage, and cryosectioning (6-8/~m) were car- 
ried out as previously described (22).  The bundles of myofibers used to 
demonstrate the ultrastructural  features of the cryofixed (36) and freeze- 
dried (9, 33) myofibers were prepared as described by Jorgensen and Mc- 
1. Abbreviation  used in this paper: WGA, wheat germ agglutinin. 
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bundles of myofibers to be used for immunocolloidal gold labeling were 
cryofixed (36), freeze-dried  (9, 33), and low temperature embedded in Low- 
icryl K4M according to the procedure of Chiovetti et al. (8, 9) as modified 
by Jorgensen and McGuffee (procedure II of reference 20) and Jorgensen 
et al. (24). Thin sections (60-80 nm) were collected on nickel grids coated 
with formvar. 
lmmunofluorescence Labeling 
Immunofluorescence staining of 6-8-#m-thick cryosections from unfixed 
adult rabbit diaphragm muscle was carried out as previously described (22). 
The sections were first labeled with one of the following mAbs: IXE112 to 
TS28 or IVD31 to SL50. The secondary antibody was F(ab')2 fragments of 
affinity-purified goat anti-mouse lgG  conjugated to  FITC  (Jackson Im- 
munoreseareh Laboratories Inc.). It was used at a dilution of 1:40. Conven- 
tional fluorescence microscopy was carried out with a  photomicroscope 
(Carl Zeiss, Inc., Thornwood, NY) provided with an epifluorescence at- 
tachment and a phase-contrast condenser. Confocal microscopy was car- 
ried out with a photomicroscope (Nikon Inc., Garden City, NY) provided 
with  a  confocai  fluorescence  imaging  system  (Lasersharp  MRC-500; 
courtesy of  Bio-Rad Laboratories Ltd.) using an argon laser for illumination 
(46). 
Histochemical Staining 
Transverse sections of unfixed rabbit diaphragm muscles were stained for 
myosin ATPase after alkaline preincubation (pH 10.4) as described by Guth 
and Samaha (15). This method specifically labels the myosin ATPase of  type 
II (fast) skeletal muscle fibers. 
ImmunocoUoidal Gold Labeling 
Immunocolloidal gold labeling of thin sections of cryofixed, freeze-dried, 
and Lowicryl K4M-embedded rabbit psoas muscle was carried out as previ- 
ously described (20, 25), except that a triple layered immunolabeling tech- 
nique was used. Briefly, the sections were first labeled with ammonium sul- 
pbate-fractionated rnAb IXEII2 (0.5  mg/mi in PBS [pH 7.4]).  Then an 
affinity-purified rabbit anti-mouse (Fc fragment) gamma globulin (Jackson 
Immunoresearch Laboratories Inc.) was used at 25 #g/ml in TBS containing 
3%  BSA.  Finally,  the sections were incubated with afffinity-purified  goat 
anti-rabbit gamma globulin-colloidal gold conjugate (3-7 run) at 0.5 mg/ml 
TBS containing .3 % BSA (Janssen Pharmaceutica, Beerse, Belgium). 
To assess the immunolabeling specificity of  the thin sections of Lowicryl 
K4M-embedded tissue, mouse gamma globulin purified from preimmune 
serum (10 #g/ml PBS) was substituted for mAb IXE112 in the immunocol- 
Ioidal  gold labeling procedure. After immunolabeling, the sections were 
first stained for 15 s in saturated aqueous uranyl acetate and then for 15 s 
in lead citrate (20). The sections were examined in a transmission electron 
microscope (7000;  Hitachi Ltd., Tokyo,  Japan). 
Results 
Biochemical Characterization  of TS28 and SLSO 
mAb IXEII2 and mAb IVD31 were obtained from a panel of 
hybridoma clones whose supernatants  recognized isolated 
transverse tubular membrane vesicles but neither light sar- 
coplasmic reticulum vesicles nor purified 1,4-dihydropyri- 
dine receptor as determined by immunodot blotting (data not 
shown).  Immunoblotting of SDS-PAGE separated purified 
membrane fractions from adult rabbit psoas muscle showed 
that mAb IXEll2 specifically binds  a  single band with an 
apparent relative molecular mass of  28,000 D present in both 
isolated triads (Fig. 1 a, lane 2) and isolated transverse tub- 
ules (Fig.  1 a,  lane 3) but absent from light sarcoplasmic 
reticulum (Fig.  1 a, lane/). The results presented in Fig.  1 
b showed that mAb IVD31 specifically binds a single band 
with an apparent relative molecular mass of  50,000 D present 
in isolated triads (Fig.  1 b, lane 2) and isolated transverse 
tubular membrane fractions (Fig.  1 b,  lane 3) but absent 
Figure 1. Immunoblot staining of rabbit skeletal muscle membrane 
fractions.  Rabbit skeletal muscle  light  sarcoplasmic  reticulum 
membranes (lane 1), triads (lane 2), and transverse tubular mem- 
branes  (lane  3)  were  prepared  as  described  in  Materials  and 
Methods and separated by SDS-PAGE  (30 #g/lane) followed  by im- 
munoblotting with monoclonal antibodies. (a) Stained with mAb 
IXEII2 to TS28; (b) stained with mAb IVD3~ to SL50. 
from light sarcoplasmic reticulum vesicles (Fig. 1 b, lane/). 
The antigens defined by mAb IXEll2 and mAb IVD31 will 
be referred to as TS28 and SL50, respectively. 
To determine whether TS28 represents a major or minor 
component of  the purified transverse tubular membrane vesi- 
cles,  an  mAb  IXEll2  affinity column  was  prepared  and 
used to remove TS28 from detergent-solubilized transverse 
tubular membrane vesicles. TS28 was solubilized from iso- 
lated transverse tubular membranes using 1% digitonin and 
0.5 M NaCI as previously described for the 1,4-dihydropyridine 
receptor (29). Comparison of the protein composition of the 
same  fractions separated  by SDS-PAGE and  stained  with 
Coomassie blue showed that the protein composition of the 
solubilized transverse tubular vesicles (Fig. 2 a, lane/) was 
indistinguishable from that of the unadsorbed fraction (Fig. 
2 a, lane 2). However, comparison of digitonin-solubilized 
transverse tubules immunoblotted with mAb IXEll2 before 
(Fig. 2 b, lane 1) and after adsorption to the mAb IXE112 
affinity column (Fig. 2 b, lane 2) showed that TS28 was com- 
pletely removed by the affinity column. These results show 
that TS28 retained on the column represents a minor protein 
component  of  the  transverse  tubular  membrane  vesicle 
fraction. 
Since TS28 has a molecular mass similar to that of the 
subunits 24-33 kD (43) of the 1,4-dihydropyridine receptor, 
we examined whether mAb IXEll2 would stain the purified 
1,4-dihydropyridine receptor and whether TS28 from digi- 
tonin-solubilized transverse tubules (Fig. 3 b, lane/), like the 
1,4-dihydropyridine receptor, would be retained on a WGA- 
Sepharose  column.  Immunoblotting  showed  that  mAb 
IXEll~  did  not recognize any of the  subunits  of the  1,4- 
dihydropyridine  receptor under either nonreducing (Fig. 3 a, 
lane 2) or under reducing conditions (not shown) and that 
TS28 is not retained on the WGA-Sepharose column (Fig. 3 
a, lane 3). These results show that TS28 is not related to any 
of the subunits of the 1,4-dihydropyridine receptor, is not a 
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skeletal muscle transverse tubular membranes adsorbed with a pro- 
tein  A-mAb  IXEll2  complex.  Digitonin-solubilized  transverse 
tubular membranes from rabbit skeletal muscle before (lane 1 ) and 
after adsorption to mAb IXEI12 conjugated to protein A (lane 2) 
were prepared as described in Materials and Methods and separated 
by SDS-PAGE (40 #g/lane)  followed by either  Coomassie  blue 
staining (a) or immunoblotting with mAb IXEII2 to TS28 (b). 
WGA-binding glycoprotein, nor is tightly associated with a 
WGA-binding glycoprotein after detergent solubilization. 
Similarly, it was examined whether SL50 was related to 
the/$  subunit  (52  kD) of the  1,4-dihydropyridine  receptor 
(Fig. 3 b, lane 2) or retained on WGA-Sepharose (Fig. 3 b, 
lane 3). The results show that SL50 is indeed retained on the 
WGA-Sepharose column (Fig. 3 b, lane 3) and therefore im- 
ply that either SL50 itself or a protein to which it is tightly 
associated is a WGA-binding glycoprotein like the 1,4-dihy- 
dropyridine  receptor.  However,  immunoblotting  of  SDS- 
PAGE separated subunits of the 1,4-dihydropyridine receptor 
with either mAb VD2~ to the/3 subunit of the  1,4-dihydro- 
pyridine receptor (Fig.  3  c, lane 2) or with mAb IVD31 to 
SL50 (Fig.  3  b,  lane 2)  showed that mAb IVD31 to SL50 
does not bind to either the/$ subunit or to any other subunits 
of the WGA-binding  1,4-dihydropyridine receptor. 
The  specificity of mAb IXEll2  for the  skeletal  muscle 
component TS28 with a  relative molecular mass of 28,000 
D  (Fig. 4 a, lane 1) was demonstrated by its ability to bind 
only one polypeptide band present in a SDS-PAGE immuno- 
blot of a postnuclear supernatant from rabbit psoas muscle 
(Fig.  4 a,  lane 2).  Similarly the specificity of mAb IVD3, 
for a component with a relative molecular mass of 50,000 D 
(Fig. 4 b, lane 1) was demonstrated by its ability to bind only 
one polypeptide band present in SDS-PAGE immunoblots of 
a postnuclear supernatant from adult rabbit skeletal muscle 
(Fig. 4  b, lane 2). 
Distribution of TS28 and SL50 in Adult Rabbit 
Skeletal Muscle In Situ 
Serial transverse cryosections from adult rabbit diaphragm 
muscle  containing  both  type  I  (slow)  and  type  II  (fast) 
myofibers were labeled with mAb IXE112 to TS28 (Fig.  5 
a) and mAb IVD3~ to SL50 (Fig. 5 b). It is noteworthy that 
examination of arterial vessels present in the cryosections af- 
ter immunolabeling showed mAb IXE112 to TS28 did label 
arterial  smooth  muscle  but  neither  fibroblasts  nor  en- 
dothelial cells, while mAb IVD31 to SL50 did not label ei- 
ther  of these  three  cell  types  (results  not  shown).  These 
results indicate that both antibodies are specific for muscle 
tissue.  Examination  of  the  sections  labeled  with  mAb 
Figure 3. Immunoblot staining of 
rabbit skeletal muscle transverse 
tubular membranes before and af- 
ter adsorption with WGA-Sepha- 
rose and of the  1,4-dihydropyri- 
dine receptor. Transverse tubular 
membranes (lane 1), the purified 
1,4-dihydropyridine receptor (lane 
2), and the void of  the WGA-Seph- 
arose column (lane 3) were pre- 
pared  as described  in Materials 
and  Methods  and  separated  by 
SDS-PAGE followed by immuno- 
blotting with monoclonal antibod- 
ies (80 #g/lane).  (a) Stained with 
rnAb IXEll2 to TS28; (b) stained 
with  mAb IVD3t  to  SL50;  (c) 
stained with mAb VD2t to the/$ 
subunit of the 1,4-dihydropyridine 
receptor. 
The Journal of Cell Biology, Volume 110, 1990  1176 Figure 4. Immunoblot ~  of rabbit skeletal muscle postauelear 
supernatant and membrane fractioas~ Ral~bit  si0fl~  etal muscle trans- 
verse tubular membranes (15 ~tg; a and b, lane 1 ) and postnuclear 
supernatant (600 lag; a  and b, lane 2) were prepared as described 
in Materials and Methods and separated by SDS-PAGE followed by 
immunoblotting with monoclonai antibodies, a and b are immuao- 
blots of the gel stained with mAbs IXEII2 to TS28 and IVD3~ to 
SL50,  respectively. 
/XEII2 showed that all skeletal myofibers were specifically 
labeled  (Fig.  5 a).  However, :some myofibers were two- to 
threefold  more inteasely  labeled than lhe  rest of the myo- 
fibers (Fig.  5  a).  Examinafi"on of the  sections labeled  with 
mAb IVD3,  st~aed  that all  m~ffibers appealed to be la- 
beled with  the same intensity ,(Fig.  5  b).  To determine  the 
fiber type distribution,  additional serial sections were histo- 
chemically  stained  for  alkaliae  stable  myosin  ATPase,  a 
specific marker of type II (fas0 fi~ea~s '(Fig. 5  c)  (15).  The 
results  suggest  that mAb  IXEll2  labels  type  II  (fast)  ap- 
proximately two- to threefold more intensely fllan it labels 
type  I  (slow)  fliers.  In  contrast  fl~e  intensity  of  mAb 
IVD3~,  labeling  of type  II (fast) ~s ind~stiaguishable  from 
flua of type I  (~kar¢)  fibers. 
Subcellular Distribution of lXl,  B and SL50 in Adult 
Skeletal Muscle.In .Situ 
TA2& Examination at higher magnification  of transverse 
cryosection of rabbit gracilis  labeled  with  mAb  IXEll2 
(Fig. 6, b and d) showed a poiygomt staining pattern  thamgh- 
out the Cytoplasm of  skeletal muscle fibers. Centers of neiglv 
boring polygons were separated :by a distance ranging from 
1.1 to  1.5 van (Fig. 6 d). The immtmofluorescee~ce staining 
pattern observed in longitudinal  cryosectiorts of fixed gra- 
ellis  muscle after labeling  with  mAb  IXE112 appeared  as 
transversely oriented  rows of discrete bright foci (Fig.  7, a 
and c).  The distribution  of the ~ersely  oriented row of 
foci .(Fig. 7  a)corresponded  to the interphase between the 
Figure 5. Distribution of TS28 and SL50 in type I (slow) and type II (fast)myofiber of rabbit diaphragm muscle. Serial transverse cryosec- 
tions of unfixed rabbit diaphragm muscle were immunofluorescently labeled with mAb IXE112 to TS28 (a) and mAb IVD3~ to SL50 (b) 
and histochemically stained for alkali-stable myosin ATPase, a marker for type II (fast) myofibers (c). Two classes of fibers can be distin- 
guished after labeling with mAb IXEI12.  The class of fibers labeled relatively intensely with mAb IXEll2 (a, star) correspond to type 
lI (fast)  fibers (c, star), while the less intensely labeled class of fibers (a, circle) correspond to type I fibers (c, circle). By contrast, the 
intensity of labeling of the cell periphery with mAb IVD3~ of type I (slow)  (b, circle) is indistinguishable from that of type II (fast)  (b, 
star) fibers. Bar, 20 #m. 
Jorgenscn et al. Novel Proteins of Transverse Tubules and Sarcolemma  | 177 Figure 6. Subcellular distribution of TS28 and SLS0 in type II (fast) myofibers of rabbit gracilis muscle. Transverse sections (5-8 #m) 
of unfixed rabbit skeletal muscle were labeled with mAb IVD3~ to SLS0 (a, c, and e) and with mAb IXEll2 to TS28 (b and d) and exam- 
ined with a conventional (a, b, and d) and a confocal (thickness of optical section 0.5 #m) UV photomicroscope  (c and e). The mAb 
IVD3t specifically labeled the cell periphery,  while specific labeling was not observed in either the internal regions of the fibers (a, c, 
and e) or in the connective tissue between the fibers (e, arrows). The apparent discontinuity of labeling at some regions of  the cell periphery 
observed with conventional microscopy was not apparent when the same section was viewed by confocal microscopy. In contrast, a polygo- 
nal staining pattern was present throughout the cytoplasm of the myofiber after labeling with mAb IXEll2 to TS28 (b and d). However, 
specific labeling of the cell periphery  was not apparent (d, arrows). Bars, 5 #m. 
A-band and the I-band as observed by viewing the same field 
by phase-contrast microscopy (Fig. 7 b). Generally, the in- 
tensity of immunofluorescence labeling of the sarcolemma 
was indistinguishable from that of the extracellular space af- 
ter labeling with mAb IXEI12 (Fig.  7  c).  This is particu- 
larly evident in the A-band regions of the sarcolemma, where 
immunofluorescence demarcation of the sarcolemma is ab- 
sent. Specific labeling of the sarcolemma was not observed 
in either transverse or longitudinal sections (Fig. 6, b and d, 
and Fig.  7  c). 
SLSO.  Examination of a  transverse cryosection of rabbit 
skeletal muscle (Fig. 6 a) immunolabeled with mAb IVD3~ 
showed that specific labeling was confined to the cell periph- 
ery and apparently absent from the interior regions of the 
skeletal muscle fibers.  To test the possibility that  specific 
labeling of transverse tubular membranes was lacking be- 
cause  positive  labeling  of transverse  tubules  (30  nm  di- 
ameter) might not provide a fluorescent signal of sufficient 
intensity  in  comparison  with  that  obtained  from the  sar- 
colemma in a  6-8-#m cryosection, the distribution of im- 
munofluorescence labeling in an 0.5-#m optical section was 
examined by confocal microscopy (46).  The results shown 
in Fig. 6, c and e, demonstrated that an 0.5-#m optical sec- 
tion from the same 5-8-#m immunolabeled section did not 
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sections of  type II myofibers  of rabbit gracilis muscle. Longitudinal 
cryoseetions of paraformaldehyde fixed (2%) adult rabbit skeletal 
muscle tissue were labeled with mAb IXEII2 to TS28 (a and c) 
and mAb IVD3m to SL50 (d). The immunofluorescence staining 
pattern in a was compared with the position of the A- and 1-bands 
in  the  same  respective  field  (mirror  image) (b)  as  viewed by 
phase-contrast microscopy. Regular fluorescent staining appeared 
as small bright loci in the interphase between the A- and I-bands 
after labeling with mAb IXEI12 to TS28 (a and c). The intensity 
of labeling with mAb IXEII2 of the sarcolemma was generally in- 
distinguishable from that of the extracellular space (c). In contrast, 
mAb IVD3t labeled only the cell periphery (d). Bars, 5 #m. 
reveal any specific labeling of  the interior regions of  the mus- 
cle cells as would be expected if transverse tubules were la- 
beled. It is noteworthy that the immunofluorescence labeling 
observed in the 0.5-#m optical section by confocal micros- 
copy is continuous and of uniform intensity along the entire 
cell periphery. The immunofluorescence staining pattern ob- 
served in longitudinal cryosections of fixed gracilis muscle 
after labeling with mAb IVD3~ showed that specific label- 
ing was confined to the cell periphery where the labeling was 
generally fairly uniformly distributed  (Fig.  7 d, arrows). 
Some sarcolemmal regions were less uniformly labeled (Fig. 
7 d, arrowheads). We believe that these regions of the sar- 
colemma  represent  imaging  of  obliquely  sectioned  sar- 
colemma. It is also possible that SL50 is more densely dis- 
tributed in the region of the sarcolemma corresponding to 
the A-band than in that corresponding to the 1-band. 
lmmunoelectron Microscopical Labeling 
The distribution of the TS28 and SLS0 in rabbit skeletal mus- 
cle as determined by immunofluorescence labeling is consis- 
tent with the idea that TS28 is densely distributed in the 
transverse  tubular  membrane  but  absent  from  the  sar- 
colemma and that SL50 is associated with the sarcolemmal 
membrane but absent from the transverse tubular membrane. 
To determine whether TS28 is confined to the transverse 
tubules the studies were extended to include the immuno- 
electron microscopical localization of TS28 in rabbit psoas 
muscle.  Preliminary studies  showed that inclusion of low 
concentrations of glutaraldehyde (0.3 %) in the 2 % parafor- 
maldehyde fixative decreased the intensity of immunofluo- 
rescence labeling to a level indistinguishable from that of the 
background. To optimize the preservation of the antigenicity 
of TS28, the muscle tissue was cryofixed, freeze-dried, and 
low temperature embedded in Lowicryl K4M (24). As previ- 
ously shown for skeletal (25) and cardiac (19, 24) muscle tis- 
sue,  cellular  membranes  are  well  preserved and  readily 
visualized  in  cryofixed  and  freeze-dried  muscle  tissue, 
provided the tissue is vapor osmicated before embedding in 
Spun'. Although the osmication step is compatible with the 
immunoelectron microscopical localization of proteins pres- 
ent in the lumen of subceUular organelles (e.g.,  10, 24), it 
unfortunately blocks immunoelectron microscopical local- 
ization of TS28 in Spurr-embedded tissue. Since osmication 
of cryofixed tissue  before low temperature embedding  in 
I.owicryl K4M is not feasible, visualization of membranes 
in Lowicryl K4M-embedded tissue is variable and less than 
optimal. However, the sarcolemma (Fig. 8, a, e, and f, SL), 
terminal cisternae (Fig. 8, a-d, TC), and transverse tubules 
(Fig. 8, a-d, T) can be identified. Occasionally, subsarco- 
lemmal vesicles (Fig. 8, a, e, and f, arrowheads)  can be dis- 
cerned while longitudinal sarcoplasmic reticulum is rarely 
visualized.  The dilation  of the transverse tubules  is  very 
likely due to the differential effect of  the cryoprotectant PVP 
(24) on the osmolarity of the cytosol and the lumen of the 
transverse  tubules.  The  dilated  transverse  tubular  mem- 
branes are well delineated in the osmicated specimen (see 
Fig. 4  of reference 25). 
Examination of electron micrographs of thin sections of 
muscle fibers labeled with mAb IXEll2 showed that >95% 
of the colloidal gold particles in the interior regions of the 
myofiber were distributed over the transverse tubules (Fig. 
8, a-d). Of these >80% were within 35 um of the transverse 
tubular membranes. The remaining 20% of the colloidal gold 
particles were found in the lumen of the transverse tubules but 
>35 nm from the transverse tubular membrane. It is, however, 
very likely that these colloidal gold particles were within 35 
nm of tangentially cut transverse tubular membrane not vis- 
nalized in the images. 
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beled with rnAb IXEll2 to TS28 by the triple layered immunocolloidal gold staining technique described in Materials and Medmds. A 
majority of the colloidal gold particles were distributed over the lumen of the transverse tubules (a-d,  T, long thin arrow). Occasionally, 
clusters of colloidal gold particles were distributed in the subsarcolemmal region of the muscle fiber (a, e, and f, arrowhead), f  shows 
a higher magnification of the boxed in area in e. Some of the clusters of colloidal gold particles in the subsarcolemmal region appeared 
to be membrane bound (f, arrowhead). The lateral portion oftbe sarcolemma (a, e, and f, SL, double-headed arrow) and the terminal 
cisternae (d, TC, arrow) were labeled at the level of the background. Z, Z-line. Bars, 0.05/zm. 
At the peripheral region of the myofibers, discrete clusters 
of colloidal gold particles were present in the subsarcolemmal 
region of the muscle fibers (Fig. 8, a, e, and f). On occasion, 
these clusters were observed to be localized over caveolae-like 
structures  (Fig.  8  a,  arrowheads),  and  membrane-bound 
structures with a diameter of 80-150 nm (Fig.  8, e and f, ar- 
rowheads).  Examination  of several  long  stretches  of sarco- 
lemma suggested that these clusters were distributed in a non- 
uniform manner. Determination of the relative distribution of 
the clusters of colloidal gold particles in relation to the A- and 
I-bands showed that ,x,50%  of these clusters were localized 
within 0.3/Jm of the A-band-I-band interface,  while the re- 
maining 50%  were localized  in the A-band regions.  In con- 
trast,  colloidal gold particles were very sparsely distributed 
over the lateral regions of the sarcolemma (Fig.  8, a, e, and 
f, SL) (<1 colloidal gold particle/10/~m).  Similarly, the myo- 
fibrils and the interfibrillar spaces, where the longitudinal sar- 
coplasmic retieulum is densely distributed,  were labeled at a 
level similar to that of the background (<1 colloidal gold par- 
ticle/lO #m). 
Attempts to immunolocalize the SL50 protein at the ultra- 
stmeanal level of resolution were unsuccessful in that imnmno- 
labeling was indistinguishable  from that of the background. 
Since reduction of the transverse tubular membranes before 
SDS-PAGE and nitrocellulose blotting prevent mAb IVD3, 
from binding to SL50,  we anticipate: that the conformation 
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IVD3~ is not recognized by this mAb after the light-induced 
polymerization of Lowicryl K4M. 
Discussion 
Two novel skeletal muscle membrane proteins, TS28 and 
SL50, have been identified and partially characterized, and 
their subeellular distribution in adult skeletal muscle in situ 
has been determined using two monoclonal antibodies pre- 
pared against isolated transverse tubular membrane vesicles. 
One of  these proteins, TS28, has an apparaent relative mo- 
lecular mass of 28,000  D and is a minor component of the 
isolated transverse tubular membranes. The association of 
TS28  with isolated transverse tubular membranes is very 
strong since TS28 is not removed during washing with high 
ionic strength buffers carried out during the isolation of  these 
membranes. In addition, TS28 does not appear to be a solu- 
ble protein present in the lumen of isolated transverse mem- 
brane vesicles since saponin did not remove TS28  (results 
not shown) like it removes rabbit serum albumin from these 
membrane vesicles (26). Immunoblotting showed that TS28 
is  neither a  WGA-binding glycoprotein nor  is  tightly as- 
sociated with a  WGA-binding glycoprotein, implying that 
TS28 is distinct from the/~ subunits (24-32 kD) of the WGA- 
binding 1,4-dihydropyridine receptor (43).  This conclusion 
was further supported by the finding that sucrose gradient 
centrifugation  of digitonin-solubilized  transverse  tubular 
membranes results in the separation of the 1,4-dihydropyri- 
dine receptor complex from the TS28 (results not shown). 
This result also showed that TS28  is not tightly associated 
with the 1,4-dihydropyridine receptor complex after deter- 
gent solubilization. Thus, biochemical studies indicate that 
TS28 is either an integral membrane protein of  the transverse 
tubular system or attached to an integral membrane protein 
of this membrane system. 
The  immunofluorescence  and  immunoelectron  micro- 
scopical studies in situ showed that TS28 is localized to the 
transverse tubules and in some subsarcolemmal vesicles pos- 
sibly corresponding to a subgroup of caveolae. In contrast, 
TS28 is absent from the lateral regions of the sarcolemma 
as well as from the sarcoplasmic reticulum. The ultrastruc- 
tural study of Ezerman and Ishikawa (12) of  developing chick 
skeletal muscle in culture was the first to show the connec- 
tion between caveolae and the transverse tubules.  Similar 
studies of guinea pig (37) and frog skeletal muscle (48) have 
shown that transverse tubules frequently terminate in caveo- 
lae, which in turn are continuous with other caveolae and the 
sarcolemma. Thus, it is possible that the TS28-1abeled sub- 
sarcolemmal vesicles represent caveolae connecting trans- 
verse tubules with the sarcolemma. 
Immunofluorescence labeling of skeletal muscle fibers in 
situ suggested that TS28 was two- to threefold more densely 
distributed in type II (fast) than in type I (slow) fibers.  This 
finding might in part be explained by the results of ultrastruc- 
tural studies showing that the density of transverse tubules 
is approximately twofold higher in type II (fast) fibers than 
in type I fibers (11). However, further studies will be required 
to determine whether or not this is the case. Comparison of 
these results with our previous immunofluorescence and im- 
munoelectron microscopical studies of the subeellular distri- 
bution of the ~  subunit of the 1,4-dihydropyridine receptor 
in rabbit skeletal muscle (25) suggest that both TS28 and the 
ol,  subunit of the  1,4-dihydropyridine receptor are present 
in the transverse tubules and in some caveolae but absent 
from the lateral portion of the sarcolemma. Although the 
function of TS28 is presently unknown, these results support 
the possibility that TS28 may regulate or function in the ex- 
citation-contraction coupling. 
The other protein, SL50, has an apparent relative molecu- 
lar mass of 50,000 D. Immunoblotting showed that SL50 is 
either a  WGA-binding glycoprotein or  that it  like  the  /3 
subunit (52,000  D) of the  1,4-dihydropyridine receptor is 
tightly associated with a WGA-binding glycoprotein (5, 7). 
However, immunoblotting of the SDS-PAGE separated sub- 
units of the 1,4-dihydropyridine receptor showed that SL50 
is  distinct from the /3  subunit of the  1,4-dihydropyridine 
receptor. 
The conventional and confocal immunofluorescence stud- 
ies of skeletal muscle in situ showed that SL50 is associated 
with the sarcolemma but apparently absent from the trans- 
verse tubules. Regarding the apparent absence of SL50 in 
transverse tubules it is important to consider whether or not 
this finding is due to inaccessibility of mAb IVD3~ to SL50 
in transverse tubules especially since recent immunocyto- 
chemical studies of cultured myotubes (Jorgensen, A. O., 
and W. Arnold, unpublished results) showed that the epitope 
of SL50 labeled by mAb IVD3, is exposed to the extracel- 
lular side of the sarcolemma. Since calsequestrin localized 
in the lumen of junctional sarcoplasmic reticulum (23,  32) 
can be immunolocalized in cultured developing myotubes 
fixed and air dried by a procedure (21) equivalent to that used 
to prepare the cryostat sections for immunolabeling in the 
present study, it is highly unlikely that the observed absence 
of SL50 in transverse tubules of adult skeletal muscle is due 
to the fact that SL50 is not accessible to mAb IVD3,. Al- 
though the  resolution of immunofluorescence microscopy 
does not permit one to conclude whether SL50 is an integral 
or an associated component of the sarcolemma, the inability 
to extract SL50 from isolated membrane vesicles, unless de- 
tergent was added to the extraction buffer, supports the con- 
tention that SL50 is an integral component of the sarcolem- 
ma. Immunofluorescence studies in situ suggested that the 
density of SL50 in type II (fast) fibers was indistinguishable 
from that of type I (slow) fibers. 
On the basis of biochemical studies, it has been reported 
that a protein with an apparent relative molecular mass of 
28,000-30,000  D  is a  major component of the transverse 
tubular membrane vesicles purified either according to the 
procedure of Rosemblatt et al. (40) or by ion-free sucrose 
density centrifugation as described by Horgan and Kuypers 
(18).  Recently, Rosemblatt and Scales (39)  identified four 
transverse tubular proteins using immunochemical and im- 
munocytochemical studies (Table  I).  They concluded that 
two of these, a 38,000-D and a 53,000-D protein, were pres- 
ent in transverse tubules but absent from the sarcolemma. In 
contrast the two other proteins with apparent relative molec- 
ular mass values of 27,500 and 105,000 D were present in 
both transverse tubules and the sarcolemma. 
Since TS28 (28,000  D) described in the present paper is 
a minor component of transverse tubules and absent from the 
sarcolemma, we conclude that TS28  is a novel component 
distinct from both the 28,000-30,000-D proteins previously 
reported to be a major component of purified transverse tu- 
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Name 
Structural  Subcellular distribution 
Tight 
association  lmmunoblotting 
Relative  WGA  with  (isolated membrane) 
molecular  glycoprotein  1,4-dihydropyridine 
mass  binding  receptor  TT~:  SL 
Immunecytochemical 
(in situ) 
Light microscopy  Electron  microscopy 




SL50  50 
1,4-dihydropyridine receptor 
subunits (5,  7) 
al  170 
a2  175 
52 
"r  32 
(5  22-33 





TT proteins (39) 
Na  + channel (16)  260 
260 
No  No  +  ND 
Yes  No  +  ND 
Yes  Yes  No 
No  Yes  Yes  ? 
Yes  Yes  Yes  ? 
No  Yes  Yes  ? 
Yes  Yes  Yes  ? 
Yes  Yes  Yes  ? 
ND  ND  ND  ND 
ND  ND  +  + 
ND  ND  +  - 
ND  ND  +  - 
ND  ND  +  + 
ND  ND  ND  + 
ND  ND  ND  + 
-  +  ND  ND 
+  -  +  - 
ND  ND  ND  ND 
+  -  ND  ND 
ND  ND  ND  ND 
ND  ND  ND  ND 
-  +  ND  ND 
+  +  ND  ND 
+  -  ND  ND 
+  -  ND  ND 
+  +  ND  ND 
+~  +  +  + 
-**  +  ND  ND 
* Demonstrated by immunoblotting and/or immunocytochemical studies. 
TT, transverse  tubular  membrane;  SL,  sarcolemmal membrane. 
,~ Does not bind Con A-Sepharose. 
I1 Slow skeletal muscle. 
** Fast skeletal muscle. 
bules (18, 40) and from the 27,500-D protein reported to be 
equally distributed  in  the  transverse tubules  and  the  sar- 
colemma (39). In contrast, SL50 (50,000-D), although iden- 
tified in isolated transverse tubules and isolated triads, was 
shown by  immunocytochemical labeling  to be associated 
with the sarcolemma but apparently absent from the internal 
regions of skeletal muscle fibers and thus absent from trans- 
verse tubules. We conclude that SL50 is confined to the sar- 
colemma  and  thus  distinct  from  the  53,000-D  protein 
identified by Rosemblatt and Scales (39) and reported to be 
present in the region of the transverse tubules but absent 
from the sarcolemma. 
Recently Schafer and Stockdale (41) identified a sarcolem- 
ma-associated antigen in chicken skeletal muscle with an ap- 
parent relative molecular mass of 55,000 D named MSA55 
(Table I). Like SL50 described in the present paper, the den- 
sity of MSA55 in type I (slow) fibers was indistinguishable 
from that 0f type II (fast) fibers. Since mAb IVD3~ does not 
label chicken skeletal muscle fibers, it is not feasible at the 
present time to determine whether MSA55  and SL50 are 
analogous proteins. 
The distinct distribution of TS28 and the ccj subunit of the 
1,4-dihydropyridine receptor (25) to the transverse tubular 
membrane and of SL50 to the sarcolemmal region of the 
skeletal muscle in situ shows directly that each of these sepa- 
rate but continuous regions of the plasma membrane contain 
unique proteins. 
Thus, our present and previous studies (25) of the subcel- 
lular distribution of transverse tubular and sarcolemmal pro- 
teins by immunocytochemical labeling of skeletal muscle tis- 
sue  in  situ  show  directly  that  each  of these  distinct  but 
continuous membranes contain some unique proteins. These 
results  support  the  concept  that  transverse  tubular  mem- 
branes and sarcolemmal membranes are specialized to carry 
out distinct functions. 
In agreement with this conclusion, Rosemblatt and Scales 
(39) used immunofluorescence labeling to demonstrate that 
two  other  proteins  present  in  isolated  transverse  tubular 
membranes were localized to the A-band-l-band interphase 
where transverse tubules are present but were absent from 
the sarcolemma (Table I).  Similarly,  Haimovich et al.  (16) 
demonstrated that an epitope on the 260,000-D  subunit of 
the Na  + channel is localized to the sarcolemma but absent 
from interior regions of fast rat skeletal fibers (Table I). 
The finding that TS28 is confined to the transverse tubular 
membrane and that SL50 is confined to the sarcolemmal re- 
gion as determined by  immunocytochemical labeling  sug- 
gests that these proteins may serve as markers for the two dis- 
tinct but continuous regions of the skeletal muscle plasma 
membrane and thus provide a tool for assaying the purity of 
isolated  sarcolemmal  and  transverse  tubular  membrane 
preparations.  The presence of SL50  in  isolated transverse 
tubular membranes is most likely due to contamination of 
these  membranes  with  sarcolemmal  membrane  vesicles. 
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the membrane preparations used in the present studies to 
be enriched in  triadic and  transverse tubular  membranes 
rather than purified triads and transverse tubular membrane 
vesicles. 
Finally, we have used mAbs to TS28 (47) and SL50 to 
study the biogenesis of the transverse tubular membranes 
and the differentiation of the sarcolemma in developing skel- 
etal muscle cells in situ. The results are presented in the ac- 
companying paper (47). 
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